Integrated Strategies to Support Diabetes Technology in Pregnancy.
Where this comes from
- Record sourced from PubMed, PMID 39208437.
- Also identified by DOI 10.1097/AOG.0000000000005710 and PMC identifier 11486578.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Managing diabetes in pregnancy can be overwhelming, with numerous dramatic physiologic changes taking place that require constant diligence and attention. Advances in diabetes technology have improved glycemic outcomes, well-being, and quality of life for people with type 1 diabetes of all ages. However, regulatory approval and access to diabetes technology in pregnancy has lagged behind these advancements, leaving many pregnant individuals without tools that could dramatically improve diabetes care before, during, and after gestation. Here, we review the benefits of continuous glucose monitors and automated insulin-delivery systems in pregnancy and highlight specific scientific and structural supports to help implement diabetes technology safely, effectively, and equitably in pregnancy.
Medical subject headings
- Pregnancy in Diabetics
- Diabetes Mellitus, Type 1
- Insulin Infusion Systems
- Blood Glucose Self-Monitoring